american biochemical and pharmaceuticals limited
american biochemical and pharmaceuticals limited Company Information
Company Number
03071923
Next Accounts
Jun 2026
Shareholders
ambipha holding llc
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
suite 1b1, argyle house, northside, northwood, middlesex, HA6 1NW
Website
http://abpcorp.comamerican biochemical and pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED at £245.5k based on a Turnover of £734.8k and 0.33x industry multiple (adjusted for size and gross margin).
american biochemical and pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED at £0 based on an EBITDA of £-443.4k and a 3.38x industry multiple (adjusted for size and gross margin).
american biochemical and pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED at £1.5m based on Net Assets of £781k and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
American Biochemical And Pharmaceuticals Limited Overview
American Biochemical And Pharmaceuticals Limited is a live company located in northwood, HA6 1NW with a Companies House number of 03071923. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in June 1995, it's largest shareholder is ambipha holding llc with a 100% stake. American Biochemical And Pharmaceuticals Limited is a mature, small sized company, Pomanda has estimated its turnover at £734.8k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
American Biochemical And Pharmaceuticals Limited Health Check
Pomanda's financial health check has awarded American Biochemical And Pharmaceuticals Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 9 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
9 Weak
Size
annual sales of £734.8k, make it smaller than the average company (£26m)
- American Biochemical And Pharmaceuticals Limited
£26m - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (5.8%)
- American Biochemical And Pharmaceuticals Limited
5.8% - Industry AVG
Production
with a gross margin of 14.8%, this company has a higher cost of product (28.6%)
- American Biochemical And Pharmaceuticals Limited
28.6% - Industry AVG
Profitability
an operating margin of -60.4% make it less profitable than the average company (3.7%)
- American Biochemical And Pharmaceuticals Limited
3.7% - Industry AVG
Employees
with 2 employees, this is below the industry average (38)
2 - American Biochemical And Pharmaceuticals Limited
38 - Industry AVG
Pay Structure
on an average salary of £79k, the company has an equivalent pay structure (£79k)
- American Biochemical And Pharmaceuticals Limited
£79k - Industry AVG
Efficiency
resulting in sales per employee of £367.4k, this is less efficient (£657.3k)
- American Biochemical And Pharmaceuticals Limited
£657.3k - Industry AVG
Debtor Days
it gets paid by customers after 122 days, this is later than average (58 days)
- American Biochemical And Pharmaceuticals Limited
58 days - Industry AVG
Creditor Days
its suppliers are paid after 20 days, this is quicker than average (28 days)
- American Biochemical And Pharmaceuticals Limited
28 days - Industry AVG
Stock Days
it holds stock equivalent to 228 days, this is more than average (64 days)
- American Biochemical And Pharmaceuticals Limited
64 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 266 weeks, this is more cash available to meet short term requirements (13 weeks)
266 weeks - American Biochemical And Pharmaceuticals Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 4.2%, this is a lower level of debt than the average (52.8%)
4.2% - American Biochemical And Pharmaceuticals Limited
52.8% - Industry AVG
AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED financials
American Biochemical And Pharmaceuticals Limited's latest turnover from September 2024 is estimated at £734.8 thousand and the company has net assets of £781 thousand. According to their latest financial statements, American Biochemical And Pharmaceuticals Limited has 2 employees and maintains cash reserves of £176.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1,539,835 | |||||||||||||||
| Other Income Or Grants | ||||||||||||||||
| Cost Of Sales | 872,874 | |||||||||||||||
| Gross Profit | 666,961 | |||||||||||||||
| Admin Expenses | ||||||||||||||||
| Operating Profit | ||||||||||||||||
| Interest Payable | 5,966 | |||||||||||||||
| Interest Receivable | 40,231 | |||||||||||||||
| Pre-Tax Profit | 628,372 | |||||||||||||||
| Tax | -108,441 | |||||||||||||||
| Profit After Tax | 519,931 | |||||||||||||||
| Dividends Paid | ||||||||||||||||
| Retained Profit | 519,931 | |||||||||||||||
| Employee Costs | ||||||||||||||||
| Number Of Employees | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 3 | |||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 421 | 561 | 748 | 997 | 5,997 | 8,315 | 9,692 | 1,855 | 3,003 | 6,283 | 17,950 | 27,893 | 38,283 | 49,253 | 2,991 | 2,265 |
| Intangible Assets | ||||||||||||||||
| Investments & Other | 983 | 983 | 983 | 369,890 | 179,186 | 1,284,471 | 1,281,787 | 1,402,660 | 992,699 | 1,050,772 | 866,456 | 982,349 | 784,599 | |||
| Debtors (Due After 1 year) | ||||||||||||||||
| Total Fixed Assets | 421 | 561 | 748 | 1,980 | 6,980 | 9,298 | 379,582 | 181,041 | 1,287,474 | 1,288,070 | 1,420,610 | 1,020,592 | 1,089,055 | 915,709 | 985,340 | 786,864 |
| Stock & work in progress | 392,734 | 592,955 | 190,449 | 290,243 | 188,174 | 176,644 | 106,172 | 185,248 | 173,418 | 68,470 | 67,991 | 123,734 | 46,968 | 71,131 | 77,246 | 112,804 |
| Trade Debtors | 246,031 | 370,255 | 198,256 | 90,223 | 63,510 | 288,256 | 235,797 | 179,525 | 222,911 | 341,062 | 151,796 | 141,635 | 145,138 | 231,410 | 157,135 | 116,212 |
| Group Debtors | ||||||||||||||||
| Misc Debtors | 7,815 | 4,257 | 6,535 | 5,449 | 1,226 | 15,631 | 363,766 | |||||||||
| Cash | 176,202 | 563,969 | 809,042 | 390,345 | 673,446 | 781,184 | 435,832 | 209,998 | 221,057 | 401,201 | 195,192 | 129,595 | 332,484 | 288,092 | 88,821 | 137,617 |
| misc current assets | ||||||||||||||||
| total current assets | 814,967 | 1,527,179 | 1,197,747 | 778,626 | 929,387 | 1,252,619 | 783,250 | 575,997 | 633,017 | 810,733 | 414,979 | 394,964 | 524,590 | 590,633 | 323,202 | 730,399 |
| total assets | 815,388 | 1,527,740 | 1,198,495 | 780,606 | 936,367 | 1,261,917 | 1,162,832 | 757,038 | 1,920,491 | 2,098,803 | 1,835,589 | 1,415,556 | 1,613,645 | 1,506,342 | 1,308,542 | 1,517,263 |
| Bank overdraft | 35 | |||||||||||||||
| Bank loan | ||||||||||||||||
| Trade Creditors | 34,340 | 321,674 | 150,425 | 211,857 | 37,771 | 98,502 | 125,983 | 147,221 | 94,848 | 1,024,508 | 996,520 | 926,730 | 964,286 | 1,123,897 | 1,014,225 | 1,036,975 |
| Group/Directors Accounts | ||||||||||||||||
| other short term finances | ||||||||||||||||
| hp & lease commitments | ||||||||||||||||
| other current liabilities | 48,756 | 382,918 | 490,601 | 441,170 | 375,062 | 494,468 | ||||||||||
| total current liabilities | 34,340 | 321,674 | 150,425 | 260,613 | 420,689 | 589,138 | 567,153 | 522,283 | 589,316 | 1,024,508 | 996,520 | 926,730 | 964,286 | 1,123,897 | 1,014,225 | 1,036,975 |
| loans | ||||||||||||||||
| hp & lease commitments | ||||||||||||||||
| Accruals and Deferred Income | ||||||||||||||||
| other liabilities | ||||||||||||||||
| provisions | 87 | 88 | 117 | 177 | 1,115 | 1,540 | 8,210 | 6,080 | 25,038 | 1,134 | 2,735 | 3,631 | 4,857 | 6,158 | ||
| total long term liabilities | 87 | 88 | 117 | 177 | 1,115 | 1,540 | 8,210 | 6,080 | 25,038 | 1,134 | 2,735 | 3,631 | 4,857 | 6,158 | ||
| total liabilities | 34,427 | 321,762 | 150,542 | 260,790 | 421,804 | 590,678 | 575,363 | 528,363 | 614,354 | 1,025,642 | 999,255 | 930,361 | 969,143 | 1,130,055 | 1,014,225 | 1,036,975 |
| net assets | 780,961 | 1,205,978 | 1,047,953 | 519,816 | 514,563 | 671,239 | 587,469 | 228,675 | 1,306,137 | 1,073,161 | 836,334 | 485,195 | 644,502 | 376,287 | 294,317 | 480,288 |
| total shareholders funds | 780,961 | 1,205,978 | 1,047,953 | 519,816 | 514,563 | 671,239 | 587,469 | 228,675 | 1,306,137 | 1,073,161 | 836,334 | 485,195 | 644,502 | 376,287 | 294,317 | 480,288 |
| Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Profit | ||||||||||||||||
| Depreciation | 140 | 187 | 249 | 2,207 | 2,318 | 2,417 | 1,780 | 1,148 | 3,280 | 12,660 | 12,562 | 12,215 | 11,963 | 10,142 | 873 | 664 |
| Amortisation | ||||||||||||||||
| Tax | -108,441 | |||||||||||||||
| Stock | -200,221 | 402,506 | -99,794 | 102,069 | 11,530 | 70,472 | -79,076 | 11,830 | 104,948 | 479 | -55,743 | 76,766 | -24,163 | -6,115 | -35,558 | 112,804 |
| Debtors | -124,224 | 171,999 | 100,218 | 30,271 | -227,024 | 53,545 | 60,495 | -57,791 | -102,520 | 189,266 | 10,161 | -3,503 | -86,272 | 74,275 | -322,843 | 479,978 |
| Creditors | -287,334 | 171,249 | -61,432 | 174,086 | -60,731 | -27,481 | -21,238 | 52,373 | -929,660 | 27,988 | 69,790 | -37,556 | -159,611 | 109,672 | -22,750 | 1,036,975 |
| Accruals and Deferred Income | -48,756 | -334,162 | -107,683 | 49,431 | 66,108 | -119,406 | 494,468 | |||||||||
| Deferred Taxes & Provisions | -1 | -29 | -60 | -938 | -425 | -6,670 | 2,130 | -18,958 | 23,904 | -1,601 | -896 | -1,226 | -1,301 | 6,158 | ||
| Cash flow from operations | ||||||||||||||||
| Investing Activities | ||||||||||||||||
| capital expenditure | ||||||||||||||||
| Change in Investments | -983 | -368,907 | 190,704 | -1,105,285 | 2,684 | -120,873 | 409,961 | -58,073 | 184,316 | -115,893 | 197,750 | 784,599 | ||||
| cash flow from investments | ||||||||||||||||
| Financing Activities | ||||||||||||||||
| Bank loans | ||||||||||||||||
| Group/Directors Accounts | ||||||||||||||||
| Other Short Term Loans | ||||||||||||||||
| Long term loans | ||||||||||||||||
| Hire Purchase and Lease Commitments | ||||||||||||||||
| other long term liabilities | ||||||||||||||||
| share issue | ||||||||||||||||
| interest | 34,265 | |||||||||||||||
| cash flow from financing | -252,690 | |||||||||||||||
| cash and cash equivalents | ||||||||||||||||
| cash | -387,767 | -245,073 | 418,697 | -283,101 | -107,738 | 345,352 | 225,834 | -11,059 | -180,144 | 206,009 | 65,597 | -202,889 | 44,392 | 199,271 | -48,796 | 137,617 |
| overdraft | -35 | 35 | ||||||||||||||
| change in cash | -387,767 | -245,073 | 418,697 | -283,101 | -107,703 | 345,317 | 225,834 | -11,059 | -180,144 | 206,009 | 65,597 | -202,889 | 44,392 | 199,271 | -48,796 | 137,617 |
american biochemical and pharmaceuticals limited Credit Report and Business Information
American Biochemical And Pharmaceuticals Limited Competitor Analysis
Perform a competitor analysis for american biochemical and pharmaceuticals limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HA6 area or any other competitors across 12 key performance metrics.
american biochemical and pharmaceuticals limited Ownership
AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED group structure
American Biochemical And Pharmaceuticals Limited has no subsidiary companies.
Ultimate parent company
AMBIPHA HOLDING LLC
#0154368
1 parent
AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED
03071923
american biochemical and pharmaceuticals limited directors
American Biochemical And Pharmaceuticals Limited currently has 2 directors. The longest serving directors include Mr Patrick Byrne (Apr 2021) and Mr Adam Small (Aug 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Patrick Byrne | United States | 83 years | Apr 2021 | - | Director |
| Mr Adam Small | United Kingdom | 47 years | Aug 2024 | - | Director |
P&L
September 2024turnover
734.8k
-44%
operating profit
-443.5k
0%
gross margin
14.8%
+3.21%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2024net assets
781k
-0.35%
total assets
815.4k
-0.47%
cash
176.2k
-0.69%
net assets
Total assets minus all liabilities
american biochemical and pharmaceuticals limited company details
company number
03071923
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
June 1995
age
30
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
September 2024
previous names
N/A
accountant
ROSS & PARTNERS
auditor
-
address
suite 1b1, argyle house, northside, northwood, middlesex, HA6 1NW
Bank
COMMERZBANK A G
Legal Advisor
-
american biochemical and pharmaceuticals limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to american biochemical and pharmaceuticals limited.
american biochemical and pharmaceuticals limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED. This can take several minutes, an email will notify you when this has completed.
american biochemical and pharmaceuticals limited Companies House Filings - See Documents
| date | description | view/download |
|---|
